Thermo Fisher completes acquisition of Clario Holdings; no deal terms disclosed in filing

THERMO FISHER SCIENTIFIC INC.

Acquisition of Clario Holdings, Inc. completed on March 24, 2026.
No purchase price, financing details, or expected synergies provided in the 8-K or press release text.
Clario is a clinical endpoint technology provider; transaction expands Thermo Fisher's clinical research services.
Press release text was not included in the filing; further details may be available separately.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.